139 related articles for article (PubMed ID: 32579550)
21. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
Marziali M; De Santis W; Carello R; Leti W; Esposito A; Isgrò A; Fimiani C; Sirianni MC; Mezzaroma I; Aiuti F
AIDS; 2006 Oct; 20(16):2033-41. PubMed ID: 17053349
[TBL] [Abstract][Full Text] [Related]
22. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1.
Lee SY; Park YK; Yoon CH; Kim K; Kim KC
BMC Med Genomics; 2019 Jan; 12(1):3. PubMed ID: 30626383
[TBL] [Abstract][Full Text] [Related]
24. Uniquely altered transcripts are associated with immune preservation in HIV infection.
Zanoni M; Aventurato ÍK; Hunter J; Sucupira MC; Diaz RS
PLoS One; 2017; 12(3):e0169868. PubMed ID: 28350860
[TBL] [Abstract][Full Text] [Related]
25. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
[TBL] [Abstract][Full Text] [Related]
26. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
[TBL] [Abstract][Full Text] [Related]
27. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
[TBL] [Abstract][Full Text] [Related]
28. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
30. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
[TBL] [Abstract][Full Text] [Related]
31. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.
Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N
AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141
[TBL] [Abstract][Full Text] [Related]
32. Immune signatures for HIV-1 and HIV-2 induced CD4
Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
[TBL] [Abstract][Full Text] [Related]
33. HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia.
Limmade Y; Fransisca L; Rodriguez-Fernandez R; Bangs MJ; Rothe C
PLoS One; 2019; 14(2):e0212432. PubMed ID: 30802257
[TBL] [Abstract][Full Text] [Related]
34. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
35. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
37. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
d'Ettorre G; Forcina G; Andreotti M; Sarmati L; Palmisano L; Andreoni M; Vella S; Mastroianni CM; Vullo V
Clin Exp Immunol; 2004 Feb; 135(2):280-5. PubMed ID: 14738457
[TBL] [Abstract][Full Text] [Related]
39. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
40. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.
Rodríguez-Gallego E; Gómez J; Pacheco YM; Peraire J; Viladés C; Beltrán-Debón R; Mallol R; López-Dupla M; Veloso S; Alba V; Blanco J; Cañellas N; Rull A; Leal M; Correig X; Domingo P; Vidal F
AIDS; 2018 Mar; 32(5):565-573. PubMed ID: 29280761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
